| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $13,662,848 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS100947 | Inflammatory regulation of epileptogenesis after status epilepticus | 000 | 7 | NIH | 12/8/2023 | $385,000 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS120327 | Blood-brain-barrier and white matter mechanisms underlying dementia | 000 | 2 | NIH | 3/7/2024 | $591,851 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS131106 | Discovery of Novel Selective Androgen Receptor Degraders (SARDs) for the Treatment of Spinobulbar Muscular Atrophy (SBMA) or Kennedy?s Disease | 000 | 1 | NIH | 12/1/2023 | $380,249 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018375 | Making Healthy Habits Stick: Extended Contact Interventions to Promote Long Term Physical Activity in African American Cancer Survivors | 002 | 2 | NIH | 3/24/2024 | $581,994 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY034425 | GRP78 signaling and retinal angiogenesis | 000 | 2 | NIH | 2/23/2024 | $511,066 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018174 | Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations | 001 | 2 | NIH | 3/22/2024 | $619,419 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018766 | Policy Pathways to Breast Health Equity in Racially Segregated Areas with Concentrated Poverty | 001 | 2 | NIH | 2/11/2024 | $337,451 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA276152 | Targeting brain and bone metastases in metastatic breast cancer for improved patient survival | 000 | 2 | NIH | 3/20/2024 | $553,406 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL166411 | Chloride channels in endothelial cells | 001 | 2 | NIH | 2/5/2024 | $564,798 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21AG081140 | Extracellular vesicles in AD-like pathology in HIV and its potential therapeutics | 000 | 2 | NIH | 2/27/2024 | $173,250 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01AI172991 | Mitigation of GI-ARS by Lactobacillus species | 000 | 2 | NIH | 11/20/2023 | $447,898 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY033005 | Predicting the risk of glaucoma from structural, functional, and genetic factors using artificial intelligence | 000 | 3 | NIH | 4/15/2024 | $440,335 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01ES033158 | Ionic mechanisms of toluene cerebrovascular actions | 000 | 3 | NIH | 2/7/2024 | $432,183 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA262112 | Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model | 000 | 3 | NIH | 3/5/2024 | $363,752 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R00HL146954 | Regulation of Lymphangiogenesis by Thrombospondin 1 | 000 | 5 | NIH | 1/19/2024 | $246,788 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | K23HL157554 | Genetic modifiers of Sickle Cell Kidney Disease | 000 | 3 | NIH | 2/2/2024 | $168,557 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA262112 | Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model | 001 | 3 | NIH | 4/18/2024 | $20,208 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AA029673 | Fetal cerebral arteries and prenatal alcohol exposure | 000 | 3 | NIH | 1/17/2024 | $559,091 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AA029270 | Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage. | 000 | 3 | NIH | 2/24/2024 | $446,014 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F30CA271570 | Identifying a transcriptional core regulatory circuitry and other critical transcription factor dependencies in H3.3 G34R/V high-grade glioma | 000 | 3 | NIH | 2/12/2024 | $43,694 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA267643 | Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk | 001 | 3 | NIH | 4/18/2024 | $31,950 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA267643 | Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk | 000 | 3 | NIH | 1/29/2024 | $575,156 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AG075813 | The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity | 000 | 3 | NIH | 11/8/2023 | $635,624 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01DA053672 | Genetics of oxycodone intake in a hybrid rat diversity panel. | 000 | 4 | NIH | 1/22/2024 | $612,314 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK128129 | Ceramides and Sphingolipids as Predictors of Incident Dysglycemia | 000 | 4 | NIH | 3/4/2024 | $411,332 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01ES031656 | Genetics of epigenetic response to high circulating glucocorticoids and organophosphorus compounds | 000 | 4 | NIH | 1/12/2024 | $580,839 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI158442 | Unlocking the cidal activity of echinocandins against Aspergillus fumigatus | 000 | 4 | NIH | 3/21/2024 | $449,016 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI152067 | Antifungal antagonism as a cause of treatment failure for invasive mycoses | 000 | 4 | NIH | 2/22/2024 | $550,291 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AG070913 | Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease | 000 | 4 | NIH | 1/15/2024 | $1,097,087 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK123001 | Development of a Theranostic Immunotherapy for Systemic Amyloidosis | 000 | 4 | NIH | 2/21/2024 | $398,970 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL155180 | PKD proteins in endothelial cells | 000 | 4 | NIH | 1/19/2024 | $542,105 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY030863 | Dynamics of calcium signals control neurotransmitter release in retinal ribbon synapses | 000 | 4 | NIH | 1/16/2024 | $380,000 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA253329 | Role of microbial-modulated bile acid receptor signaling in breast cancer | 000 | 5 | NIH | 4/12/2024 | $380,449 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK125586 | Circulating microbiome and premature mortality in hemodialysis patients | 000 | 5 | NIH | 2/15/2024 | $337,224 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DA048017 | Reduced complexity mapping of oxycodone self-administration and stress responsiveness in rats | 000 | 5 | NIH | 2/28/2024 | $309,338 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI143197 | Non-cyp51A-mutation Mediated Triazole Resistance in Aspergillus fumigatus | 000 | 5 | NIH | 4/5/2024 | $656,395 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R24EY029950 | Novel Extended Release Glaucoma Therapy for Once Daily Dosing | 001 | 5 | NIH | 4/11/2024 | $905,799 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI140405 | Adipose T cell microRNAs (miRs) regulate macrophage function during obesity | 000 | 5 | NIH | 1/16/2024 | $337,421 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL149662 | Chloride channels in diabetic vascular disease | 000 | 5 | NIH | 11/30/2023 | $380,000 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI134796 | Candidalysin: a key mediator of Candida vaginitis immunopathology | 001 | 5 | NIH | 2/1/2024 | $415,675 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK138872 | Regulation of kidney function and blood pressure in aging | 000 | 1 | NIH | 3/29/2024 | $611,240 |
| 2024 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL019134 | Angiotensins, Prostaglandins and Adrenergic Interactions | 002 | 48 | NIH | 3/19/2024 | $686,841 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018375 | Making Healthy Habits Stick: Extended Contact Interventions to Promote Long Term Physical Activity in African American Cancer Survivors | 000 | 1 | NIH | 1/4/2024 | $0 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018375 | Making Healthy Habits Stick: Extended Contact Interventions to Promote Long Term Physical Activity in African American Cancer Survivors | 001 | 1 | NIH | 3/13/2024 | $0 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | T6852013 | Maternity Care Nursing Workforce Expansion (MatCare) Training Program | 01 | 1 | HRSA | 4/22/2024 | $0 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | T4852037 | Nurse Education, Practice, Quality and Retention Simulation Education Training Program | 01 | 1 | HRSA | 11/3/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | 90DDUC0133 | Center on Developmental Disabilities (University Center for Excellence in Developmental Disabilities) | 01 | 1 | ACL | 2/8/2024 | $0 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | P1349612 | Rural Residency Planning and Development Program | 03 | 1 | HRSA | 10/6/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018174 | Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations | 000 | 1 | NIH | 3/20/2024 | $0 |
|